To: Cogito Ergo Sum who wrote (6756 ) 4/21/2011 5:44:07 PM From: eucalypt 4 Recommendations Read Replies (1) | Respond to of 16592 There are three issue to think about. 1. Share weakness arising in part from a confusing press release. 2. Interpreting the news release. 3. Future share placements First, share weakness. Even before the press release some people were talking about short selling. Remember that the two private placements in December have statutory holding periods that expire on 1st and 12th May respectively. Some clients who were introduced to Amazon are unlikely to treat this as anything other than a short-term investment. If you have a broad portfolio that has gone nowhere for the last 10 years you are likely to have some incentive to lock into some profits - and your broker would like to have some bragging rights. My conclusion is that the desire to take some profits and the fear of losing the fabulous profit (they have doubled their money) is responsible for the sell off, which may continue for another few weeks. For long term holders this is irrelevant. Second, the news release. We can't draw any conclusions at this stage. We need to plead that in future all such statements are proof read by competent scientists fluent in English and Portuguese. To me, the word "coarse" implies a larger particle size than "granules", so the statement "the Company did not previously observe these characteristics when it supplied ThermoPotash in coarse form as opposed to granules" makes no sense. I will remain unenlightened until I see the research data what is meant by "control". In an email last year (sorry I haven't kept it) I asked either Iwona Zakrzewski or Derek Fray about whether Amazon had looked at comminution and screening for particle size. The response was that Amazon understood this opportunity but felt that they had other ways of dealing with this - presumably adjusting the time in the lime kiln, formulations and treatment schedule. The significant feature of a no result would be that the KCL will be long gone, but the TP is still there and if you want slow release then you have got it! Sounds stupid, but if you are growing eucalypts on a 6-7 year rotation getting a deferred (and unquantified) benefit would be welcome. ALL SPECULATION UNTIL WE GET THE SCIENTIFIC REPORT. Third, to bore everyone to tears. This company is, or is going to be, a Brazilain company. IMO it will not be sold to Vale. More likely it will be partnered in some way by the companies who formulate/distribute fertilizers in Minais Gerais. Why? Simply because Amazon has no interest in moving downstream into distribution. They said so at the London Brokers meeting last November. Why? Because distribution was a low margin business. Logic would then dictate that those who are already in that low margin business will be looking to increase profitabilty by capturing some of the upstream business. At the same time Amazon has some obligation to UK/Canadian brokers who have raised the profile of AMZ, so I speculate that there will be a further private placement off-shore concurrent with a large offering within Brazil, possibly towards year end. If you are an investor you swallow your short-term disappointment over a poorly written and confusing press release. There will be better days ahead.